Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Ovary Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchEnded earlyNCT00253461
What this trial is testing

11C Topotecan PET Imaging

Who this might be right for
Lung CancerMetastatic CancerOvarian Cancer+1 more
Case Comprehensive Cancer Center 7
Large-scale testing (Phase 3)Study completedNCT03940196
What this trial is testing

Effect of Tumor Treating Fields (TTFields, 200 kHz) Concomitant With Weekly Paclitaxel for the Treatment of Recurrent Ovarian Cancer (ENGOT-ov50 / GOG-3029 / INNOVATE-3)

Who this might be right for
Ovarian Cancer
NovoCure Ltd. 540
Not applicableTemporarily pausedNCT03987555
What this trial is testing

Paclitaxel Therapeutic Drug Monitoring in Cancer Patients

Who this might be right for
Solid Tumor, AdultMetastatic Nonsmall Cell Lung CancerAnatomic Stage IV Breast Cancer AJCC v8+25 more
Wake Forest University Health Sciences 55
Early research (Phase 1)Looking for participantsNCT06515613
What this trial is testing

CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors

Who this might be right for
Platinum-resistant Ovarian CancerTesticular CancerEndometrial Cancer
Context Therapeutics Inc. 156
Testing effectiveness (Phase 2)Study completedNCT01611558
What this trial is testing

Phase II Study of Ipilimumab Monotherapy in Recurrent Platinum-sensitive Ovarian Cancer

Who this might be right for
Platinum-sensitive Ovarian Cancer, Second-line, Third-line, or Fourth-line
Bristol-Myers Squibb 40
Early research (Phase 1)Study completedNCT00005858
What this trial is testing

LMB-9 Immunotoxin in Treating Patients With Advanced Colon, Breast, Non-small Cell Lung, Bladder, Pancreatic, or Ovarian Cancer

Who this might be right for
Bladder CancerBreast CancerColorectal Cancer+3 more
University of Maryland, Baltimore 25
Testing effectiveness (Phase 2)Active Not RecruitingNCT04781088
What this trial is testing

Lenvatinib, Pembrolizumab, and Paclitaxel for Treatment of Recurrent Endometrial, Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Platinum-Resistant Fallopian Tube CarcinomaPlatinum-Resistant Ovarian CarcinomaPlatinum-Resistant Primary Peritoneal Carcinoma+4 more
Floor Backes, MD 38
Early research (Phase 1)Study completedNCT00058435
What this trial is testing

Monoclonal Antibody Vaccine Therapy in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)UnknownNCT03942068
What this trial is testing

Apatinib With Albumin-bound Paclitaxel in Patients With Platinum-resistant Recurrent Ovarian Cancer

Who this might be right for
Ovarian Cancer
Henan Cancer Hospital 35
Testing effectiveness (Phase 2)Looking for participantsNCT07714668
What this trial is testing

A Clinical Study of SYS6041 Combination Therapy for Recurrent Ovarian Cancer

Who this might be right for
Ovarian CancerRecurrent Ovarian Cancer
CSPC Megalith Biopharmaceutical Co.,Ltd. 171
Early research (Phase 1)Active Not RecruitingNCT04670068
What this trial is testing

Phase I Study of Autologous CAR T-Cells Targeting the B7-H3 Antigen in Recurrent Epithelial Ovarian

Who this might be right for
Epithelial Ovarian Cancer
UNC Lineberger Comprehensive Cancer Center 4
Early research (Phase 1)Study completedNCT03586661
What this trial is testing

Niraparib and Copanlisib in Treating Patients With Recurrent Endometrial, Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Who this might be right for
Deleterious BRCA1 Gene MutationDeleterious BRCA2 Gene MutationEndometrial Adenocarcinoma+8 more
M.D. Anderson Cancer Center 31
Early research (Phase 1)Study completedNCT00006391
What this trial is testing

Oxaliplatin and Topotecan in Treating Patients With Previously Treated Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPeritoneal Cavity Cancer
NYU Langone Health
Testing effectiveness (Phase 2)Active Not RecruitingNCT06028932
What this trial is testing

Sacituzumab Govitecan (IMMU-132) in Platinum-resistant Ovarian Cancer Patients

Who this might be right for
Ovarian Carcinoma
Yale University 20
Large-scale testing (Phase 3)Looking for participantsNCT05255471
What this trial is testing

MITO 35B: Olaparib Beyond Progression Compared to Platinum Chemotherapy After Secondary Cytoreductive Surgery in Recurrent Ovarian Cancer Patients.

Who this might be right for
Ovarian Cancer
National Cancer Institute, Naples 200
Testing effectiveness (Phase 2)UnknownNCT04734665
What this trial is testing

Niraparib and Bevacizumab Maintenance Therapy in Platinum-sensitive Recurrent Ovarian Cancer Patients Previously Treated With a PARP Inhibitor

Who this might be right for
Platinum-sensitive Recurrent Ovarian Cancer Patients Previously Treated With a PARP Inhibitor
Yonsei University 44
Early research (Phase 1)Study completedNCT01264432
What this trial is testing

Veliparib and Radiation Therapy in Treating Patients With Advanced Solid Malignancies With Peritoneal Carcinomatosis, Epithelial Ovarian, Fallopian, or Primary Peritoneal Cancer

Who this might be right for
Adult Solid NeoplasmPeritoneal CarcinomatosisRecurrent Fallopian Tube Carcinoma+2 more
National Cancer Institute (NCI) 34
Early research (Phase 1)Study completedNCT01322802
What this trial is testing

Vaccine Therapy in Treating Patients With Stage III-IV or Recurrent Ovarian Cancer

Who this might be right for
Stage III Ovarian Epithelial CancerStage III Ovarian Germ Cell TumorStage IV Ovarian Epithelial Cancer+1 more
University of Washington 25
Testing effectiveness (Phase 2)Ended earlyNCT00023907
What this trial is testing

Paclitaxel in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer

Who this might be right for
Ovarian CancerPrimary Peritoneal Cavity Cancer
Gynecologic Oncology Group
Testing effectiveness (Phase 2)Ended earlyNCT06865677
What this trial is testing

Sacituzumab Govitecan for Relapsed Ovarian, Endometrial, and Cervical Carcinomas

Who this might be right for
Recurrent Platinum Resistant Epithelial Ovarian CarcinomaRecurrent Epithelial Endometrial CarcinomaRecurrent Epithelial Cervical Carcinoma
National Cancer Institute (NCI) 2
Next Page